Andere Sprachen Pharmacolog i Uppsala AB

Aktien

A3DWNW

SE0019071812

PHLOG B

Markt geschlossen - Nasdaq Stockholm Andere Börsenplätze 16:08:35 19.04.2024			% 5 Tage	% 1. Jan.
0.105 ^SEK	0.00%		+10.76%	+85.51%

04.04.	Pharmacolog i Uppsala AB (publ) gibt die Ernennung von Anders Hedlund zum Interims-CEO mit Wirkung zum 1. Mai 2024 bekannt	CI
01.03.	Pharmacolog kündigt den Rücktritt von Lars Gusch als CEO mit Wirkung zum 30. April 2024 an	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024	16.04.
Pharmacolog publishes annual report for 2023	16.04.
Nolsterby Invest AB has increased its holding in Pharmacolog	08.04.
Pharmacolog announces the appointment of Anders Hedlund as interim CEO	04.04.
Pharmacolog i Uppsala AB Announces the Appointment of Anders Hedlund as Interim CEO, Effective from May 1, 2024	04.04.
NOTICE TO EXTRAORDINARY GENERAL MEETING IN PHARMACOLOG I UPPSALA AB (PUBL)	14.03.
Pharmacolog provides update on new business direction and proposes name change	14.03.
Pharmacolog announces upcoming change in management	01.03.
Pharmacolog Announces Resignation of Lars Gusch as CEO, Effective from April 30, 2024	01.03.
Warrants of series TO3 were subscribed to approximately 90.4 percent and Pharmacolog receives approximately SEK 2.3 million	27.02.
Major shareholder in Pharmacolog exercises warrants of series TO3 for at least approximately SEK 0.54 million	20.02.
The last day of trading with warrants of series TO3 in Pharmacolog is today, February 20, 2024	20.02.
Year-end bulletin Pharmacolog 2023	16.02.
Pharmacolog i Uppsala AB Reports Earnings Results for the Full Year Ended December 31, 2023	16.02.
Pharmacolog i Uppsala AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	16.02.
Pharmacolog investigates the possibilities for a new business direction	15.02.
Pharmacolog terminates the partnership agreement with Codonics with immediate effect	14.02.
Pharmacolog AB Terminates the Partnership Agreement with Codonics Inc	14.02.
Pharmacolog divests part of its operations to RaySearch Laboratories AB	09.02.
The exercise period for warrants of series TO3 begins today	09.02.

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Pharmacolog i Uppsala AB

Aktien

A3DWNW

SE0019071812

PHLOG B

Andere Sprachen

Filter